bar right time
consolid
altogeth end rough note quest lab industri
equival revenu came lower alreadi revis lower
forecast repres declin y/i remind quest lower
revenu forecast late-novemb analyst day relat
predominantli revers account receiv balanc sheet
compani took addit adjust appear de-risk balanc
sheet also impact quarterli result surpris anoth leg
quarter though one silver line volum growth appear
improv compani note good start adjust ep
modestli better forecast addit quest
activ capit deploy repurchas stock toward
acquisit toward dividend
ultim share trade new ep forecast
believ sentiment near trough despit potenti leverag share gain
view structur trend back nation lab
consolid test share quest time shine believ open
nation payor network major shift lab industri break barrier
consolid volum addit payor incent encourag physician
patient choos high qualiti laboratori deliv good valu benefit
nation lab scale advantag final believ industri pressur
outsiz impact region hospital-bas lab given outsiz exposur pama
cut payor effort reign cost bar right low thesi
work think quest need string togeth coupl quarter consist
result start earn convict back thesi reiter overweight
though reduc pt base lower earn trajectori start
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
lower usd
return equiti ttm
link barclay live interact chart
overweight believ quest long
runway deliv strategi acceler growth
deliv oper excel point new
payor relationship help drive lab test share
toward nation lab time addit
believ quest meaning leverag
diagnost data asset custom
upsid case assum quest aggreg
increment test share drive upsid
case ep earn begin
acceler believ multipl room
expans well given long runway
downsid case assum softer util
well increment wage pressur busi
cost repres downsid
case ep
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
altogeth end rough note quest lab industri equival
revenu came lower alreadi revis lower forecast
repres declin y/i remind quest lower
revenu forecast late-novemb analyst day relat predominantli
revers account receiv balanc sheet compani took addit
adjust appear de-risk balanc sheet also impact quarterli
result surpris anoth leg quarter though one silver
line volum growth appear improv compani note
good start adjust ep modestli better forecast
addit quest activ capit deploy repurchas
stock toward acquisit toward dividend
ultim share trade new ep forecast believ
sentiment near trough despit potenti leverag share gain
view structur trend back nation lab consolid test
share quest time shine believ open nation payor network
major shift lab industri break barrier consolid volum
addit payor incent encourag physician patient choos high qualiti
laboratori deliv good valu benefit nation lab scale advantag
final believ industri pressur outsiz impact region hospital-
base lab given outsiz exposur pama cut payor effort reign cost
bar right low thesi work think quest need string togeth
coupl quarter consist result start earn convict back thesi
reiter overweight though reduc pt base lower earn
trajectori start
lower price target shown figur price
target repres blend blend ep scenario analysi also
yield multipl ep forecast prior price target
repres prior ep forecast
price base weight averag scenario analysi
quest initi guidanc revenu expect ep
modestli floor quest expect adjust revenu
billion repres revenu growth y/i embed growth rate
epsmultipleoutcomerel pricenotesbas lab share revenue upsid epsdownsid volum wage pressur barclay quest diagnost
 model impli organ growth expect
year compani embed share gain payor contract
chang guidanc compani quantifi anticip tailwind quest
provid detail around expect headwind payor polici chang patient
concess hcv dynam outlin observ two
compani provid tax rate interest rate expect emb
unannounc capit deploy estim
adj ep expect expect modestli prior
estim impli ep growth y/i embed ep
guidanc greater million headwind reimburs pressur
believ stem larg pama unitedhealthcar price declin addit quest
expect gener cffo deploy capital-expenditure
quest provid number updat phase ep guidanc
million reimburs headwind expect evenli spread throughout year
quest easi comparison a/r adjust creat
headwind one less revenu day one extra revenu day
volum contract chang expect build throughout year though
compani go face increment cost support volum
revenu forecast flat y/i ep expect flat
quest report billion revenu quarter repres equival
growth y/i inc equival growth lower estim
alreadi revis lower compani late novemb analyst day
updat revenu laboratori test decreas revenu
y/i revenu per requisit decreas y/i though note includ
account receiv adjust quarter compani size headwind
million one bright spot volum increas y/i
stronger estim adjust acquisit contribut
weather calendar estim underli util increas y/i
would improv recent trend
quest comment three test area repres headwind growth
includ prescript drug monitor hepat genotyp vitamin
prescript drug monitor quest note payor implement polici
chang limit growth test quest note annual
restrict polici two payor continu forecast headwind
categori
hepat genotyp quest seen declin genotyp resist
test attribut new hepat therapi work across
multipl gene requir test quest expect lap signific
headwind dynam
vitamin test quest note volum slow due increas
reimburs denial quest note work payor provid
ensur appropri test perform patient need includ
patient co-morbid condit compani note lap polici
chang major payor march though continu expect continu
pressur pure denial arent headwind volum physician start
chang behavior around order neg impact volum
patient concess quest note seen impact larger percentag
revenu come patient compar insur stem
greater preval hdhp well higher deduct within plan
alreadi high deduct increas patient concess forecast
continu headwind
quarterli revenu million organ growth
underli driver revenu growth quest
quest see earli sign share gain payor network chang
expect volum build throughout continu believ improv health
plan access other repres signific opportun
quest view open aetna network first time
sinc opportun quest labcorp consolid share
fragment lab industri remind quest labcorp announc new contract
may view game-chang industri
previous quest labcorp exclus relationship aetna
respect open januari quest size share
gain opportun around billion compani think could drive
upsid new long-term growth compound-annual-growth-rate revenu growth
earn growth new relationship unitedhealthcar horizon
georgia quest ad total million increment live
quest believ market share plan today goal reach
share posit line commerci share current in-network plan end
given new live repres billion revenu opportun
share would impli billion revenu goal payor next three year
quest alreadi see small initi pick-up broaden access
quest continu expect bolu share gain start
build compani move year expand reach addit
account quest note initi volum come compani loyalist account
benefit small doctor awar sensit potenti patient
impact send test current out-of-network
lab
geograph compani perform best area legaci strength
assumptionstot growth equival trial total test y/i lab organ total requisit y/i y/i organ net new weather calendar underli ppa per y/i y/i organ rev medicar pama overal y/i organ growth clinic dx rev pre- debt lab y/i y/i organ total barclay quest diagnost
new york area florida texa quest ad volum come
labcorp lot lab new york metro area hope
quest labcorp collect gain share network access open januari
believ compani trade multipl would benefit valu
proposit versu hospit region lab reson market quest physician
target strategi expect broaden time compani evalu
account order laboratori test current activ custom
within total quest see short-term target describ
loyalist mix beyond compani medium-term target
anoth long-term total target sinc june quest note
contact account
final see anoth catalyst juli implement prefer
laboratori network quest go await addit commun
weigh note implement cant hurt think could big
deal share save prefer lab volum shift
high-cost set first lab industri volum shift high-cost
provid toward prefer network plan develop pool
save share provid instead commodit lab lab
result qualiti metric differenti particip price tool
incentiv effici deliveri care encourag util prefer network
consid put place econom incent patient
physician adher network would also first histori
lab industri would includ waiv out-of-pocket cost patient co-pay
deduct encourag adopt given rapid growth high-deduct health
plan past decad believ could drive strong incent patient
better direct shift volum given differenti invest quest
labcorp put consum tool real-tim auto adjud vs region
peer two nation lab would obviou beneficiari prefer network
implement
commentari prefer lab network
prefer lab network featur current contract laboratori care provid met higher standard
access cost data qualiti servic standard help us work lab improv care provid
current reach free-stand lab alreadi particip unitedhealthcar network invit
appli join prefer lab network program summer well announc inform
program along lab includ prefer lab network believ addit tier
prefer statu favor quest labcorp given compani advantag valu proposit consum tool
real-tim price capabl look forward learn addit detail
clearli much bigger opportun quest labcorp test consolid
lab across payor repres industri look back
past decad obviou nobodi origin nation exclus
contract nation lab nation payor patient clear
nation payor recogn need work nation lab better drive
valu system old contract allow region lab better penetr physician
offic could arbitrag benefit fact nation lab out-
of-network one nation payor drove higher price nation payor
overal higher out-of-pocket cost patient quest believ old payor
paradigm drove complex physician would field question
patient around unexpect lab cost back in-network remov unnecessari
barrier compet nation lab believ share could move quickli
commerci execut get messag number
get larg quickli current valuat believ investor free call option
potenti consolid upsid outsid hospit lab opportun size
around billion nation lab repres share obviou
headwind account prefer peer quest equal need defend
turf number get larg quickli current valuat believ investor
effect free call option potenti consolid upsid outsid
hospit lab opportun size around billion nation lab repres
share everi market share assum meaning price discount quest
fee schedul yield million addit revenu quest growth quest
estim increment margin would impli earn growth almost
pull-through believ best outcom investor lab industri
consolid organ payor drive share nation lab hand
without need cash outlay
outsid hospit opportun
increment ep increment share gain
quest activ new acquisit partnership divestitur
continu see signific runway consolid laboratori test
beyond continu believ effort provid better healthcar integr
patient cost share greater regul fda ldt reimburs pressur
pama driver share consolid toward effici provid quest
labcorp organ growth modest compani done effect
job win new busi hospit partnership acquisit compani
spent million million full year
increment revenu growthincrement share pieincrement quest rev mminc marginpric discount quest fee schedul barclay quest diagnost
believ reimburs pressur drive lab consolid smaller competitor
lack scale drive effici busi margin come increas
pressur quest announc seven partnerships/d mark acceler
rel recent year compani less activ begin though
announc number deal last month addit quest vocal
robust pipelin potenti deal compani expect growth deal provid
larger impact state guidanc transact improv visibl
top line growth help off-set price headwind pama quest organ
hospit relationship two strategi
profession lab servic pl quest work hospit offer lab manag
servic within hospit inpati outpati procedur area save
includ refer work integr quest test network procur save
quest purchas scale employe manag product improv
contract negoti hospit way allow hospit save
money quest make margin inpati outpati test
servic typic bundl part drg code given procedur reimburs
medicar part ipp opp respect hospit
unwil part lab ownership give quest opportun
gener instant save reson new relationship notabl
shown chart quest announc pl arrang barnaba
new jersey hca one hospit network denver montefior
outreach acquisit absent integr deal quest activ
acquisit hospit outreach test hospit outreach compet directli
two nation lab busi gener physician offic altern site
follow acquisit hospit lab revenu get reset lower onto labcorp
quest fee schedul major payor sizabl reduct
greater despit rate reset nation lab believ abl drive
signific effici still achiev ebitda margin mid-teen
independ affili barclay quest diagnost
 clinic laboratori acquisit partnership
pleas see report
quest continu believ pama creat meaning headwind medicar
reimburs remind implement pama kick
largest chang diagnost reimburs year result confirm
belief pama lead meaning medicar cut time lead period
heighten lab industri consolid pama expect serv headwind
compani medicar revenu financi impact still
meaning yet manag given medicar clf repres quest
revenu assum drop-through price reduct equat ep
headwind medicar reimburs chang actual
sizabl survey work interact lab director suggest industri
experi period meaning consolid ultim believ smaller lab
outsiz medicar exposur consolid time either organ
inorgan benefit labcorp quest industri leader
quot headlin medicar cut clf time roughli
code see rate decreas vs rate increas code
rate reduct greater labcorp quest estim around
top code see rate reduct annual first year reduct
increasingli sever routin test estim top
hcpc code clf spend cut altogeth top code
contribut clf spend almost million claim
design top code gener billion clf payment
top code cut genom health oncotyp dx top code
increas top code cut impli
medicar reimburs payment still weight median
averag addit anoth three test cut display magnitud
futur cut top code includ lipid panel reduct
code contribut nearli clf spend code drug
test def class new volum weight median pama reduct
yeardealslabtarget/partnerdatetyp bynum patholog laboratori lab gener outreach medic outreach lab immunotec us lab lab lab acquisitionlabcorpappalachian region servicesquestcalifornia laboratori associ outreach acquisitionquestcleveland clinic servicesquesthartford outreach acquisitionquestshiel medic laboratori jvquestcap cod healthcar outreach acquisitionquestm fusion associ medic laboratori laboratori outreach acquisit servicessonicwestern connecticut health network venturequestmontefior health serviceslabcorpmount acquisitionlabcorpclearpath lab lab acquisitionquesthca serviceslabcorphenri mayo newel acquisitionquestclin laboratori partner hartford health outreach acquisit barclay quest diagnost
overal continu believ signific rate reduct routin code
lead increas outsourc effici provid labcorp quest
top hcpc code clf spend
potenti off-set horizon data collect
process similar process two import chang relat
definit applic lab influenc survey pool first chang
medicar advantag revenu exclud total medicar revenu threshold
second signific chang enabl hospit lab without uniqu npi
applic lab medicar revenu meet major
medicar revenu low expenditur threshold decis broaden definit
includ hospit lab come receiv much critic limit
hospit lab particip previou pama survey even addit hospit lab
particip still expect labcorp quest repres vast major data
submit part survey routin test though broader particip could
limit risk around addit cut clear chang view
expect medicar rate cut pama rate lock
data report period remind data report take place everi
year said think market may view posit given potenti
rate increas relief futur cut current model addit cut
make adjust weather calendar impact acquisit new
busi underli util appear strengthen overal volum
grew quarter emb contribut acquisit sever
deal contribut growth follow adjust estim underli
util y/i q/q quest encourag
volum prescript drug monitor tb test cardio
hcpc codehcpc code descriptiontot claim linestot payment total nlaweight median payment w/ payment w/ payment w/ thyroid stim metabol cbc w/auto diff hemoglobin test def panel total test def parathormon psa free culture/coloni test def test def natriuret colorect breast cbc folic acid suscept barclay quest diagnost
note organ volum growth adjust
note organ adjust volum growth adjust weather notabl net new busi calendar
revenu per requisit compris unit price variat busi mix test mix
quarter compani took revenu account receiv charg due
updat revenu recognit assumpt compani size headwind
million outsid issu believ pama headwind rev-per-
req line prior expect combin test factor contribut
price headwind includ higher patient concess payor
denial quest expect price headwind greater
estim pama serv headwind believ pressur
contract repres major remaind
note organ reimburs growth adjust fx beacon lb labcorp adjust mix
sg expect sg ex- stock comp
percentag revenu y/i q/q stock-bas comp
million came well estim million quarter similar cog
creat optic headwind sg revenu
sg trend revenu
adjust ebit decreas y/i million came
estim million oper margin weaken y/i came
higher forecast compani account receiv charg
quarter signific headwind margin reduct revenu doesnt
carri cost offset
adj margin trend revenu
cffo came expect million versu estim
million differ driven work capit use vs model
repres adj net incom quarter capital-expenditure million
repres revenu estim million final quest
deploy million dividend sharehold toward
compani also repurchas share quarter bring total
buyback quest continu gener signific free cash flow
priorit toward return sharehold estim compani exit
net debt ttm ebitda par histor level
use oper million
million except per share dataestestestestestestestestincom increas debt debt debt gross lab increas equival organ increas net margin net sg net comp sg net increas intang oper ebitda margin net oper profit ebit margin net interest expens debt share earn joint expens pre-tax pre-tax provis incom tax net net average share average share ep ep increas item net net increas ens net incom growth net ep growth barclay quest diagnost
 mm except ep reportedincom growth ebitda ebit pre-tax tax net adj net researchprior yearprior quarter barclay
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
